<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="article-commentary" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">104040</article-id><article-id pub-id-type="doi">10.7554/eLife.104040</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Stem Cells and Regenerative Medicine</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Notch Signaling</subject></subj-group></article-categories><title-group><article-title>Antibodies get under the skin</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Levra Levron</surname><given-names>Chiara</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1057-9792</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Chiara Levra Levron</bold> is in the Department of Life Sciences and Systems Biology and the Molecular Biotechnology Center “Guido Tarone”, University of Turin, Torino, Italy</p></bio></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Piacenti</surname><given-names>Gabriele</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9775-2863</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Gabriele Piacenti</bold> is in the Department of Life Sciences and Systems Biology and the Molecular Biotechnology Center “Guido Tarone”, University of Turin, Torino, Italy</p></bio></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Donati</surname><given-names>Giacomo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0370-8288</contrib-id><email>giacomo.donati@unito.it</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Giacomo Donati</bold> is in the Department of Life Sciences and Systems Biology and the Molecular Biotechnology Center “Guido Tarone”, University of Turin, Torino, Italy</p></bio></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048tbm396</institution-id><institution>Department of Life Sciences and Systems Biology and the Molecular Biotechnology Center “Guido Tarone”, University of Turin</institution></institution-wrap><addr-line><named-content content-type="city">Torino</named-content></addr-line><country>Italy</country></aff></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>30</day><month>10</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e104040</elocation-id><permissions><copyright-statement>© 2024, Levra Levron, Piacenti et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Levra Levron, Piacenti et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-104040-v1.pdf"/><related-article related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.7554/eLife.98747" id="ra1"/><abstract><p>By inhibiting receptor-ligand interactions in sebaceous glands, antibodies may be able to treat certain skin conditions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>notch signaling</kwd><kwd>therapeutic antibodies</kwd><kwd>cell fates</kwd><kwd>differentiation</kwd><kwd>stem cell</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>By inhibiting receptor-ligand interactions in sebaceous glands, antibodies may be able to treat certain skin conditions.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>Template</meta-name><meta-value>1</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Abidi SNF, Chan S, Seidel K, Lafkas D, Vermeulen L, Peale F, Siebel CW. 2024. The Jag2/Notch1 signaling axis promotes sebaceous gland differentiation and controls progenitor proliferation. <italic>eLife</italic> <bold>13</bold>:RP98747. doi: <ext-link ext-link-type="uri" xlink:href="http://doi.org/10.7554/eLife.98747">10.7554/eLife.98747</ext-link>.</p></boxed-text><p>As the outer organ of the body, the skin has many roles, from defending against microbes to regulating body temperature and sensations. To exercise these duties, it takes advantage of various types of cells, tissues and glands. Sebaceous glands – which are found in hair follicles all over the body, apart from the palms of our hands and the soles of our feet – produce a lipid-rich liquid called sebum, which prevents the skin from becoming too dry. Sebum also helps protect against bacterial and fungal infections, and can have pro- and anti- inflammatory effects.</p><p>The cells that produce sebum are called sebocytes, and they undergo a process of differentiation that starts with stem cells in the peripheral zone, followed by a period in the maturation zone (where the sebocytes accumulate lipids and become enlarged), before they move to the degeneration zone and burst, releasing sebum into the sebaceous duct, which carries it to the skin surface (<xref ref-type="fig" rid="fig1">Figure 1A</xref>; <xref ref-type="bibr" rid="bib2">Geueke and Niemann, 2021</xref>; <xref ref-type="bibr" rid="bib6">Oulès et al., 2020</xref>). Defective sebaceous glands have been linked to numerous skin conditions, including alopecia, acne vulgaris, psoriasis and seborrheic dermatitis, as well as tumors such as sebaceoma, sebaceous adenoma and carcinoma (<xref ref-type="bibr" rid="bib5">Oulès et al., 2019</xref>). Therefore, there is a clear need for a better understanding of the molecular mechanisms underpinning the development and workings of the sebaceous glands.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Inside the sebaceous gland.</title><p>(<bold>A</bold>) Schematic representation of a sebaceous gland. Stem cells (pink) in the peripheral zone differentiate to become sebocytes (green) as they move into the maturation zone. The process of differentiation continues, and the fully differentiated cells (purple) then move into the degeneration zone, where they accumulate lipids and increase in size. Eventually the sebocytes burst and the lipid-filled sebum travels to the skin via the sebaceous duct (orange). (<bold>B</bold>) The Notch signaling pathway is activated when the ligand Jag2 (blue) binds to the Notch1 receptor (red). This pathway drives the process of differentiation in the sebaceous gland, from stem cells to mature sebocytes (left). The interaction between Jag2 and Notch1 can be blocked with anti-Jag2 antibodies (grey and blue Y-shape) or anti-Notch1 antibodies (grey and red Y-shape). This, in turn, blocks sebocyte differentiation, leading to an increase in the number of stem cells and a reduction in the number of mature sebocytes (right).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-104040-fig1-v1.tif"/></fig><p>The Notch signaling pathway is a key regulator of stem cell differentiation and is known to impact sebaceous glands. The pathway is activated when transmembrane Notch receptors bind to their corresponding ligands on the surface of sebocytes. Mammals express four Notch receptors (called Notch1, 2, 3, and 4), and five ligands have been described (Jag1 and 2, and Delta-like1, 3 and 4; <xref ref-type="bibr" rid="bib4">Nowell and Radtke, 2013</xref>; <xref ref-type="bibr" rid="bib10">Zhou et al., 2022</xref>). Previous work has shown that deleting the gene for Notch2 in mice does not affect sebaceous glands (<xref ref-type="bibr" rid="bib7">Pan et al., 2004</xref>). Other research has shown that genetically ablating Notch1 in adult mice suppresses the differentiation of sebocytes (<xref ref-type="bibr" rid="bib9">Veniaminova et al., 2019</xref>), but the identity of the ligand required to activate the pathway remained a mystery. Now, in eLife, Syeda Nayab Fatima Abidi, Christian Siebel and colleagues at Genentech report using monoclonal antibodies to show that Notch1 and Jag2 ligand are required for sebocyte differentiation in mice (<xref ref-type="bibr" rid="bib1">Abidi et al., 2024</xref>).</p><p>First, using two different monoclonal antibodies that bind specifically to and inhibit either Notch1 or 2 (<xref ref-type="bibr" rid="bib3">Lafkas et al., 2015</xref>), Abidi et al. showed that only inhibiting Notch1 reduced the differentiation of the cells in sebaceous glands, confirming its primary role in regulating sebocyte fate. Next, the team focused on identifying the Notch ligands involved. Experiments with two specific antibodies against Jag1 and Jag2 revealed that blocking Jag1 did not affect sebocyte differentiation. However, when Jag2 was blocked, very few mature sebocytes were produced, and the gland was mostly filled with immature proliferating cells that had not differentiated (<xref ref-type="fig" rid="fig1">Figure 1B</xref>).</p><p>Since the antibodies used to inhibit Notch1 and Jag2 are eventually cleared from the system, the researchers were able to study if the transient inhibition of Notch1-Jag2 binding had permanent consequences. They found that, after antibody clearance, Notch activity was re-established and sebocyte differentiation also recovered, revealing that the transient Notch1-Jag2 inhibition had only temporary impacts on the differentiation process, without limiting the potential of the stem cells in the gland. Furthermore, these antibodies seemed to specifically affect the sebaceous glands and had little or no impact on other components of the skin such as the adipocytes and the interfollicular epidermis.</p><p>The value of monoclonal antibodies from a clinical perspective is evident: they show remarkable target specificity and numerous antibody therapies have already been approved for clinical use (<xref ref-type="bibr" rid="bib8">Shepard et al., 2017</xref>). The reversibility of the effects induced by anti-Jag2 antibodies provides translational potential for disorders involving sebocyte overactivity, such as acne. These antibodies also have the advantage that they seem to only affect the differentiation of sebaceous glands, with negligible effects on other cellular components of the skin.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abidi</surname><given-names>SNF</given-names></name><name><surname>Chan</surname><given-names>S</given-names></name><name><surname>Seidel</surname><given-names>K</given-names></name><name><surname>Lafkas</surname><given-names>D</given-names></name><name><surname>Vermeulen</surname><given-names>L</given-names></name><name><surname>Peale</surname><given-names>F</given-names></name><name><surname>Siebel</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>The Jag2/Notch1 signaling axis promotes sebaceous gland differentiation and controls progenitor proliferation</article-title><source>eLife</source><volume>13</volume><elocation-id>RP98747</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.98747</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geueke</surname><given-names>A</given-names></name><name><surname>Niemann</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Stem and progenitor cells in sebaceous gland development, homeostasis and pathologies</article-title><source>Experimental Dermatology</source><volume>30</volume><fpage>588</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1111/exd.14303</pub-id><pub-id pub-id-type="pmid">33599012</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafkas</surname><given-names>D</given-names></name><name><surname>Shelton</surname><given-names>A</given-names></name><name><surname>Chiu</surname><given-names>C</given-names></name><name><surname>de Leon Boenig</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Stawicki</surname><given-names>SS</given-names></name><name><surname>Siltanen</surname><given-names>C</given-names></name><name><surname>Reichelt</surname><given-names>M</given-names></name><name><surname>Zhou</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Eastham-Anderson</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>H</given-names></name><name><surname>Roose-Girma</surname><given-names>M</given-names></name><name><surname>Chinn</surname><given-names>Y</given-names></name><name><surname>Hang</surname><given-names>JQ</given-names></name><name><surname>Warming</surname><given-names>S</given-names></name><name><surname>Egen</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>WP</given-names></name><name><surname>Austin</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Payandeh</surname><given-names>J</given-names></name><name><surname>Lowe</surname><given-names>JB</given-names></name><name><surname>Siebel</surname><given-names>CW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Therapeutic antibodies reveal Notch control of transdifferentiation in the adult lung</article-title><source>Nature</source><volume>528</volume><fpage>127</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.1038/nature15715</pub-id><pub-id pub-id-type="pmid">26580007</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nowell</surname><given-names>C</given-names></name><name><surname>Radtke</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Cutaneous Notch signaling in health and disease</article-title><source>Cold Spring Harbor Perspectives in Medicine</source><volume>3</volume><elocation-id>a017772</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a017772</pub-id><pub-id pub-id-type="pmid">24296353</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oulès</surname><given-names>B</given-names></name><name><surname>Rognoni</surname><given-names>E</given-names></name><name><surname>Hoste</surname><given-names>E</given-names></name><name><surname>Goss</surname><given-names>G</given-names></name><name><surname>Fiehler</surname><given-names>R</given-names></name><name><surname>Natsuga</surname><given-names>K</given-names></name><name><surname>Quist</surname><given-names>S</given-names></name><name><surname>Mentink</surname><given-names>R</given-names></name><name><surname>Donati</surname><given-names>G</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mutant Lef1 controls Gata6 in sebaceous gland development and cancer</article-title><source>The EMBO Journal</source><volume>38</volume><elocation-id>e100526</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2018100526</pub-id><pub-id pub-id-type="pmid">30886049</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oulès</surname><given-names>B</given-names></name><name><surname>Philippeos</surname><given-names>C</given-names></name><name><surname>Segal</surname><given-names>J</given-names></name><name><surname>Tihy</surname><given-names>M</given-names></name><name><surname>Vietri Rudan</surname><given-names>M</given-names></name><name><surname>Cujba</surname><given-names>AM</given-names></name><name><surname>Grange</surname><given-names>PA</given-names></name><name><surname>Quist</surname><given-names>S</given-names></name><name><surname>Natsuga</surname><given-names>K</given-names></name><name><surname>Deschamps</surname><given-names>L</given-names></name><name><surname>Dupin</surname><given-names>N</given-names></name><name><surname>Donati</surname><given-names>G</given-names></name><name><surname>Watt</surname><given-names>FM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Contribution of GATA6 to homeostasis of the human upper pilosebaceous unit and acne pathogenesis</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>5067</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-18784-z</pub-id><pub-id pub-id-type="pmid">33082341</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>MH</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>HT</given-names></name><name><surname>Gridley</surname><given-names>T</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Kopan</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Gamma-secretase functions through Notch signaling to maintain skin appendages but is not required for their patterning or initial morphogenesis</article-title><source>Developmental Cell</source><volume>7</volume><fpage>731</fpage><lpage>743</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.09.014</pub-id><pub-id pub-id-type="pmid">15525534</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shepard</surname><given-names>HM</given-names></name><name><surname>Phillips</surname><given-names>GL</given-names></name><name><surname>D Thanos</surname><given-names>C</given-names></name><name><surname>Feldmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Developments in therapy with monoclonal antibodies and related proteins</article-title><source>Clinical Medicine</source><volume>17</volume><fpage>220</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.7861/clinmedicine.17-3-220</pub-id><pub-id pub-id-type="pmid">28572223</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veniaminova</surname><given-names>NA</given-names></name><name><surname>Grachtchouk</surname><given-names>M</given-names></name><name><surname>Doane</surname><given-names>OJ</given-names></name><name><surname>Peterson</surname><given-names>JK</given-names></name><name><surname>Quigley</surname><given-names>DA</given-names></name><name><surname>Lull</surname><given-names>MV</given-names></name><name><surname>Pyrozhenko</surname><given-names>DV</given-names></name><name><surname>Nair</surname><given-names>RR</given-names></name><name><surname>Patrick</surname><given-names>MT</given-names></name><name><surname>Balmain</surname><given-names>A</given-names></name><name><surname>Dlugosz</surname><given-names>AA</given-names></name><name><surname>Tsoi</surname><given-names>LC</given-names></name><name><surname>Wong</surname><given-names>SY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Niche-specific factors dynamically regulate sebaceous gland stem cells in the skin</article-title><source>Developmental Cell</source><volume>51</volume><fpage>326</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2019.08.015</pub-id><pub-id pub-id-type="pmid">31564613</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Long</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Chu</surname><given-names>Q</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Notch signaling pathway: architecture, disease, and therapeutics</article-title><source>Signal Transduction and Targeted Therapy</source><volume>7</volume><elocation-id>95</elocation-id><pub-id pub-id-type="doi">10.1038/s41392-022-00934-y</pub-id><pub-id pub-id-type="pmid">35332121</pub-id></element-citation></ref></ref-list></back></article>